AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Greenbaum, AB Harrington, RA Hudson, MP MacAulay, CM Wilcox, RG Simoons, ML Berdan, LG Guerci, A Cokkinos, DV Kitt, MM Lincoff, AM Topol, EJ Califf, RM Ohman, EM
Citation: Ab. Greenbaum et al., Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes, J AM COL C, 37(2), 2001, pp. 492-498

Authors: Lincoff, AM Harrington, RA Califf, RM Hochman, JS Guerci, AD Ohman, EM Pepine, CJ Kopecky, SL Kleiman, NS Pacchiana, CM Berdan, LG Kitt, MM Simoons, ML Topol, EJ
Citation: Am. Lincoff et al., Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition - Insights from the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 102(10), 2000, pp. 1093-1100

Authors: Kleiman, NS Lincoff, AM Flaker, GC Pieper, KS Wilcox, RG Berdan, LG Lorenz, TJ Cokkinos, DV Simoons, ML Boersma, E Topol, EJ Califf, RM Harrington, RA
Citation: Ns. Kleiman et al., Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes, CIRCULATION, 101(7), 2000, pp. 751-757

Authors: Barsness, GW Buller, C Ohman, M Schechter, E Pucillo, A Taylor, MA Miller, MJ Reiner, JS Churchill, D Chandler, AB Gonzalez, M Smith, J Tommaso, C Berdan, LG Wildermann, NM Hasdai, D Holmes, DR
Citation: Gw. Barsness et al., Reduced thrombus burden with abciximab delivered locally before percutaneous intervention saphenous vein grafts, AM HEART J, 139(5), 2000, pp. 824-829

Authors: McClure, MW Berkowitz, SD Sparapani, R Tuttle, R Kleiman, NS Berdan, LG Lincoff, AM Deckers, J Diaz, R Karsch, KR Gretler, D Kitt, M Simoons, M Topol, EJ Califf, RM Harrington, RA
Citation: Mw. Mcclure et al., Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome - The platelet glycoprotein IIb IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial experience, CIRCULATION, 99(22), 1999, pp. 2892-2900

Authors: Mahaffey, KW Harrington, RA Simoons, ML Granger, CB Graffagnino, C Alberts, MJ Laskowitz, DT Miller, JM Sloan, MA Berdan, LG MacAulay, CM Lincoff, AM Deckers, J Topol, EJ Califf, RM
Citation: Kw. Mahaffey et al., Stroke in patients with acute coronary syndromes - Incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 99(18), 1999, pp. 2371-2377

Authors: Alexander, JH Harrington, RA Tuttle, RH Berdan, LG Lincoff, AM Deckers, JW Simoons, ML Guerci, A Hochman, JS Wilcox, RG Kitt, MM Eisenberg, PR Califf, RM Topol, EJ Karsh, K Ruzyllo, W Stepinska, J Widimsky, P Boland, JB Armstrong, PW
Citation: Jh. Alexander et al., Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes, AM J CARD, 83(8), 1999, pp. 1147-1151

Authors: Harrington, RA Califf, RM Holmes, DR Pieper, KS Lincoff, AM Berdan, LG Thompson, TD Topol, EJ
Citation: Ra. Harrington et al., Is all unstable angina the same? Insights from the Coronary Angioplasty Versus Excisional Atherectamy Trial (CAVEAT-I), AM HEART J, 137(2), 1999, pp. 227-233
Risultati: 1-8 |